Resources
Browse by
Case Study: Enable an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months
WuXi TIDES delivered what many thought was impossible: an IND-ready conjugated cyclic peptide program in just 10 months.
Process Development and Large-scale Manufacturing of the Key Northern Fragment of Enlicitide Decanoate
A new publication by MSD in Organic Process Research & Development details the process development and large-scale manufacturing of the key Northern Fragment of Enlicitide Decanoate.
Case Study: Accelerating Next-Generation Oral Cyclic Peptide from Lead Optimization to GMP Readiness
Discover how WuXi TIDES’ innovative CRDMO platform accelerated discovery and development of a groundbreaking oral peptide drug for weight control.
Inspiring Hope on Rare Disease Day 2025: Exploring DMD and Next-Generation PMO/PPMO Therapies with WuXi TIDES
Every year on Rare Disease Day, patients, families, and researchers join forces to draw attention to the unmet needs of those living with rare diseases. In honor of Rare Disease
A Comparison of 11-Monomer PNA synthesis
A Comparison of 11-Monomer PNA synthesis: Literature Protocol vs. Our Enhanced Method Our Advantages: No need of Tenta Gel resin High crude purity High yield Fast reaction time Download Full
The Role of Benchmarking Critical Impurity Control in Therapeutic Oligonucleotide Phosphoramidites
The growing need for oligonucleotide therapeutics aimed at larger patient populations has driven the demand for high-quality nucleoside phosphoramidite which are building blocks for oligonucleotide therapeutics. The global oligonucleotide therapeutics
